Phase II Trial of TAS-102 in Colorectal Cancer Patients With Circulating Tumor DNA-Defined Minimal Residual Disease After Adjuvant Therapy: INTERCEPT-TT A multiplex QIF assay was optimized on tissue ...
Senescent cells walk a tightrope, risking cell death with high levels of iron and other damaging agents, but compensating for this by overproducing a protective protein, GPX4, which staves off death.
OBERKOCHEN, Germany, April 15, 2026 /PRNewswire/ -- Revolune, a new life science company focused on enabling clearer insights from complex biological systems, today announced its official launch. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results